tiprankstipranks

Christopher Ogden Insider Profile

4 Followers
Christopher Ogden, CFO at CytomX Therapeutics, holds 103.19K shares in CytomX Therapeutics (Ticker: CTMX).
tipranks
Christopher Ogden

Christopher Ogden
CytomX Therapeutics (CTMX)
CFO

Ranked #38,015 out of 98,042 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+6.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$142K
100.00%
A breakdown of Christopher Ogden's holdings

Insider Roles

CytomX Therapeutics
(CTMX)
CFO
Roles that Christopher Ogden holds in companies

Most Profitable Insider Trade

Stock:
CytomX Therapeutics
(CTMX)
Rating:Informative Sell
Date:Mar 21, 2024 - Today
Return:+38.30%
The most profitable trade made by Christopher Ogden

Christopher Ogden's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CytomX Therapeutics
Jun 14, 2024
CFO
Uninformative Buy
$142.40K
Success Rate for
CTMX
2 out of 3 profitable transactions on
CTMX
67%
Average Return for
CTMX
Average return per transaction on
CTMX
+6.37%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 06, 2023
Uninformative Buy
$0.00
-
$0.00
Jan 19, 2024
Uninformative Buy
$0.00
-
$0.00
Jun 14, 2024
Uninformative Buy
$0.00
-
$0.00
Dec 19, 2023
Uninformative Buy
$9.69K
-
$1.41
Mar 20, 2023
Informative Sell
$1.02K
-
$1.97
-23.30%
List of latest transactions for each holding click on a transaction to see Christopher Ogden's performance on stock

Christopher Ogden insider profile FAQ

What is the percentage of profitable transactions made by Christopher Ogden?
The percentage of profitable transactions made by Christopher Ogden is 67%.
    What is the average return per transaction made by Christopher Ogden?
    The average return per transaction made by Christopher Ogden is 6.30%.
      What stocks does Christopher Ogden hold?
      Christopher Ogden holds: CTMX stocks.
        What was Christopher Ogden’s latest transaction?
        Christopher Ogden latest transaction was an Uninformative Buy of ―.
          What was Christopher Ogden's most profitable transaction?
          Christopher Ogden’s most profitable transaction was an Informative Sell of CTMX stock on March 21, 2024. The return on the trade was 38.30%.
            What is Christopher Ogden's role in CytomX Therapeutics?
            Christopher Ogden's role in CytomX Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.